Have a feature idea you'd love to see implemented?
Let us know!
KOSS Koss Corp
Price (delayed)
$7.05
Market cap
$65.56M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$62.73M
Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data
Highlights
The quick ratio has surged by 85% since the previous quarter and by 38% year-on-year
The gross margin is up by 10% since the previous quarter
Koss's EPS has plunged by 111% YoY but it has increased by 17% from the previous quarter
Koss's net income has plunged by 111% YoY but it has increased by 14% from the previous quarter
KOSS's revenue is down by 6% year-on-year
The equity has declined by 2.1% year-on-year
Key stats
What are the main financial stats of KOSS
Market
Valuations
Earnings
Shares outstanding
9.3M
Market cap
$65.56M
Enterprise value
$62.73M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.09
Price to sales (P/S)
5.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.11
Revenue
$12.27M
EBIT
-$1.02M
EBITDA
-$824,574
Free cash flow
-$652,291
Per share
Balance sheet
Liquidity
EPS
-$0.1
Free cash flow per share
-$0.07
Book value per share
$3.37
Revenue per share
$1.33
TBVPS
$4.02
Total assets
$37.2M
Total liabilities
$6.05M
Debt
$0
Equity
$31.15M
Working capital
$20.62M
Debt to equity
0
Current ratio
16.89
Quick ratio
12.45
Net debt/EBITDA
3.44
Margins
Efficiency
Dividend
EBITDA margin
-6.7%
Gross margin
34.1%
Net margin
-7.8%
Operating margin
-15.3%
Return on assets
-2.5%
Return on equity
-3%
Return on invested capital
-3.1%
Return on capital employed
-2.9%
Return on sales
-8.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOSS stock price
How has the Koss stock price performed over time
Intraday
0.43%
1 week
0%
1 month
-2.35%
1 year
151.79%
YTD
110.45%
QTD
-4.6%
Financial performance
How have Koss's revenue and profit performed over time
Revenue
$12.27M
Gross profit
$4.19M
Operating income
-$1.87M
Net income
-$950,911
Gross margin
34.1%
Net margin
-7.8%
Koss's net margin has shrunk by 112% YoY but it has increased by 11% QoQ
Koss's net income has plunged by 111% YoY but it has increased by 14% from the previous quarter
The operating income has soared by 92% YoY and by 14% from the previous quarter
KOSS's operating margin has surged by 92% year-on-year and by 12% since the previous quarter
Growth
What is Koss's growth rate over time
Valuation
What is Koss stock price valuation
P/E
N/A
P/B
2.09
P/S
5.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.11
Koss's EPS has plunged by 111% YoY but it has increased by 17% from the previous quarter
KOSS's P/B is 109% above its last 4 quarters average of 1.0 but 23% below its 5-year quarterly average of 2.7
The equity has declined by 2.1% year-on-year
The stock's P/S is 122% above its last 4 quarters average of 2.4 and 52% above its 5-year quarterly average of 3.5
KOSS's revenue is down by 6% year-on-year
Efficiency
How efficient is Koss business performance
Koss's ROS has plunged by 113% YoY but it has increased by 21% from the previous quarter
The company's return on equity has shrunk by 112% YoY but it rose by 14% QoQ
Koss's ROA has plunged by 112% YoY but it has increased by 14% from the previous quarter
KOSS's ROIC has shrunk by 110% YoY but it is up by 21% QoQ
Dividends
What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOSS.
Financial health
How did Koss financials performed over time
The quick ratio has surged by 85% since the previous quarter and by 38% year-on-year
The current ratio has soared by 62% from the previous quarter and by 38% YoY
Koss's debt is 100% lower than its equity
The equity has declined by 2.1% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.